Artificial Intelligence

#Artificial intelligence (AI) #Biologics #Drug discovery

Enabling AI in chemistry and biologics discovery

This paid-for advertorial from CDD Vault appeared in DDW Volume 26 – Issue 4, Fall 2025   CDD Vault outlines what to look for in an SDMP across chemistry and biologics using examples from CDD Vault and other leading platforms.  AI and machine learning are accelerating structure-activity relationship (SAR) predictions… Read More

#Exclusive Content

Drug discovery concept
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Guide #Machine learning

Read the Guide: How AI is transforming drug discovery

Artificial intelligence (AI) for drug discovery and development can appear somewhat elusive at times. We have fullyadvanced AI capabilities in several parallel sectors and industries, but experts are cautious to label AI a cure-all, one-shot solution. While technology-driven sectors like cyber security or engineering, for instance, showcase the effects of AI-driven solutions easily, the… Read More

#News

#Artificial intelligence (AI)

Guide: How AI is transforming drug discovery

“How AI is transforming drug discovery” is an exclusive guide published by DDW that examines the challenges and opportunities this technology is presenting throughout the industry.   It features stories on how AI is shaping drug discovery, how RNA-targeted drug discovery is being pioneered by AI and how the technology… Read More

#DDW Guides

#Artificial intelligence (AI) #Drug discovery

Transforming drug discovery with AI and digital labs – custom webinar with Sapio Sept 2025

In this webinar, hosted by DDW and supported by Sapio Sciences, join Dr Rajesh Kumar, Senior Director of Structural Biology at Schrödinger, as he explores how advanced computational methods, AI, and machine learning are revolutionising drug discovery. Dr Kumar highlights how Schrödinger’s physics-based simulations and Free Energy Perturbation (FEP) technology… Read More

#Webinars

#Artificial intelligence (AI) #Computational chemistry #Digital workflow #Drug discovery #Machine learning #Webinar

Transforming drug discovery with AI and digital labs: Last chance to register

A new FREE TO ATTEND webinar ‘Transforming drug discovery with AI and digital labs‘, hosted by DDW and supported by Sapio Sciences, is now open for registrations. On 15 September at 4pm BST, join Dr Rajesh Kumar, Senior Director of Structural Biology at Schrödinger, as he explores how advanced computational… Read More

Webinar date:
Supported by Sapio Sciences
#News

#Artificial intelligence (AI) #Computational chemistry #Digital workflow #Drug discovery #Machine learning #Webinar

Webinar: Evaluate billions of compounds in record time

A new FREE TO ATTEND webinar ‘Transforming drug discovery with AI and digital labs‘, hosted by DDW and supported by Sapio Sciences, is now open for registrations. On 15 September at 4pm BST, join Dr Rajesh Kumar, Senior Director of Structural Biology at Schrödinger, as he explores how advanced computational… Read More

Webinar date:
Supported by Sapio Sciences
#News

#Drug discovery #Foundational model #Genomics #Large language model (LLM) #Machine learning #Merck #Open source

Merck shares foundation model with the research community

Merck is expanding access to TEDDY (Transformers for Enabling Drug DiscoverY), its foundation model for drug discovery, by adding it to HuggingFace, the premier platform for open-source machine learning and LLMs.  TEDDY was created in partnership with the Boston Consulting Group (BCG) AI Science Institute and is… Read More

#News

Fibrosis lungs
#3D imaging #Artificial intelligence (AI) #Calluna Pharma #Idiopathic pulmonary fibrosis #Imaging #Phase II trial #Qureight

AI 3D imaging platform supports Calluna’s IPF trial

Calluna Pharma will use Qureight’s AI-powered imaging and clinical data curation platform to support its Phase II AURORA study.   Qureight will analyse imaging data from adult patients, evaluating anatomical lung changes in individuals treated with CAL101, Calluna’s lead asset for the treatment of idiopathic pulmonary fibrosis (IPF). Read More

#News

Digital technology concept
#Artificial intelligence (AI) #Computational chemistry #Digital workflow #Drug discovery #Machine learning #Webinar

Webinar: AI and digital workflows reshape pharmaceutical R&D

A new FREE TO ATTEND webinar ‘Transforming drug discovery with AI and digital labs‘, hosted by DDW and supported by Sapio Sciences, is now open for registrations. On 15 September at 4pm BST, join Dr Rajesh Kumar, Senior Director of Structural Biology at Schrödinger, as he explores how advanced computational… Read More

Webinar date:
Supported by Sapio Sciences
#News

#Artificial intelligence (AI) #Clinical trial design #Clinical trials #Drug discovery

The next generation of clinical trials with AI

Niven R Narain, President and CEO, BPGbio, looks at how biology-first Bayesian causal AI is redefining success in drug development. From using AI-based computational modelling to phase out animal testing for monoclonal antibodies1, to deploying its proprietary large language model-powered tool, Elsa, to read, write, and summarise regulatory documents—reducing review time… Read More

#Exclusive Content

#Artificial intelligence (AI)

Rewiring Drug Development: The Strategic Power of Pathology and AI for Biopharma R&D – on-demand webinar with Proscia Aug 2025

Digital pathology and AI are fundamentally transforming how biopharma companies discover, develop, and deliver life-changing medicines. As a result, today’s leaders aren’t debating whether to invest in digital pathology—they’re racing to scale it, unlocking faster breakthroughs, smarter clinical trials, and broader patient access to next-generation therapies.   Organisations that move… Read More

#Webinars

#Artificial intelligence (AI) #Computational chemistry #Digital workflow #Drug discovery #Machine learning #Webinar

Webinar: How is AI revolutionising drug discovery?

A new FREE TO ATTEND webinar ‘Transforming drug discovery with AI and digital labs‘, hosted by DDW and supported by Sapio Sciences, is now open for registrations. On 15 September at 4pm BST, join Dr Rajesh Kumar, Senior Director of Structural Biology at Schrödinger, as he explores how advanced computational… Read More

Webinar date:
Supported by Sapio Sciences
#News

#Artificial intelligence (AI) #Automation / robotics #Drug discovery #Hit identification #Hit to lead

Unlocking hit-to-lead efficiency through AI and automation

Veronica DeFelice, Director of Biologic Products at Sapio Sciences, looks at how the hit-to-lead process in drug discovery is being impacted by AI and automation. Complexity at the core of hit-to-lead Hit-to-lead (H2L) screening is a critical phase in drug discovery, where researchers narrow down large libraries of compounds, small molecules,… Read More

#Exclusive Content

#App note #Artificial intelligence (AI) #Drug discovery #Imaging

App Note: Your AI-enhanced solution for viral infectivity analysis

Discover how the Agilent BioTek Cytation cell imaging multimode reader and ViQi’s AVIA provide a powerful, integrated solution for viral infectivity analysis. Download the Application Note to explore how this innovative approach offers key advantages over traditional assays, including: High-throughput, cost-effective analysis: AVIA minimises reagent use, incubation time, and replicate… Read More

#News

Digital pathology
#Artificial intelligence (AI) #Biopharma #Computational chemistry #Events #Pathology #Webinar

Webinar: The impact of digital pathology and AI on drug discovery

Digital pathology and AI are fundamentally transforming how biopharma companies discover, develop, and deliver life-changing medicines. As a result, today’s leaders aren’t debating whether to invest in digital pathology—they’re racing to scale it, unlocking faster breakthroughs, smarter clinical trials, and broader patient access to next-generation therapies. Organisations that move quickly… Read More

Webinar date:
Sponsored by Proscia
#News

#Artificial intelligence (AI) #Computational chemistry #Digital workflow #Drug discovery #Machine learning #Webinar

Webinar: Transforming drug discovery with AI and digital labs

A new free to attend webinar ‘Transforming drug discovery with AI and digital labs‘, hosted by DDW and supported by Sapio Sciences, is now open for registrations. On 15 September at 4pm BST, join Dr Rajesh Kumar, Senior Director of Structural Biology at Schrödinger, as he explores how advanced computational… Read More

Webinar date:
Supported by Sapio Sciences
#News